BioSpace News Archive

Pictured: Woman in lab coat, safety glasses, and g

Sponsored: In mRNA Production, You Get Out What You Put In

Choose your raw materials wisely

April 10, 2023

·

2 min read

AbbVie_© AbbVie Inc. All rights reserved.

Drug Development

AbbVie, J&J Pull Two Accelerated Approvals for Imbruvica

AbbVie and Johnson & Johnson will withdraw the accelerated approvals for Imbruvica in mantle cell lymphoma and marginal zone lymphoma, the companies announced Thursday.

April 10, 2023

·

2 min read

·

Tristan Manalac

John Tlumacki/The Boston Globe via Getty Images

Business

In Another Round of Cuts, Biogen Lays Off Unspecified Number of Employees

The Boston Business Journal reported the layoffs would affect the multiple sclerosis team, but Biogen declined to confirm the details.

April 10, 2023

·

2 min read

·

Tristan Manalac

Business

NanoString to Release First Quarter 2023 Operating Results and Host Conference Call on Wednesday, May 3, 2023

NanoString Technologies, Inc., a leading provider of life science tools for discovery and translational research, announced that the Company will report first quarter 2023 operating results after the close of the market on Wednesday, May 3, 2023.

April 10, 2023

·

2 min read

Pharm Country

Cara Therapeutics Announces Presentation at the 22nd Annual Needham Virtual Healthcare Conference

Cara Therapeutics, Inc. today announced that Christopher Posner, President and Chief Executive Officer, will present a company overview at the 22nd Annual Needham Virtual Healthcare Conference on Monday, April 17, 2023, at 1:30 p.m. EDT.

April 10, 2023

·

1 min read

Drug Development

Evecxia Therapeutics Reports Favorable Data From a Phase 1 Single-Ascending Dose and Multiple-Ascending Dose Trial of Adjunctive EVX-101 in Healthy Volunteers Treated With a First-Line Antidepressant

Evecxia Therapeutics, Inc. today announced favorable safety, tolerability, pharmacokinetic, and pharmacodynamic data from a double-blind, placebo-controlled Phase 1, a two-part single ascending dose (SAD) and multiple ascending dose (MAD) trial of EVX-101 in healthy volunteers treated with escitalopram.

April 10, 2023

·

5 min read

Business

Aviceda Therapeutics Announces Strategic Partnership with Queen’s University Belfast (QUB)

Aviceda is partnering with world-renowned scientist Professor Christopher Scott and his teams at the Patrick G. Johnson Centre for Cancer Research at Queen’s University Belfast to spearhead development of the next generation of glyco-immune therapeutics.

April 10, 2023

·

5 min read

Business

Organogenesis Holdings Inc. to Report First Quarter of Fiscal Year 2023 Financial Results on May 10, 2023

Organogenesis Holdings Inc. today announced that first quarter of fiscal year 2023 financial results will be reported after the market closes on Wednesday, May 10th.

April 10, 2023

·

1 min read

ProMIS Neurosciences Announces Submission of Investigational New Drug (IND) Application for Lead Antibody PMN310

ProMIS Neurosciences Inc. today announced the submission of an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) for PMN310 for the treatment of AD.

April 10, 2023

·

5 min read

Genetown

Rhythm Pharmaceuticals to Present at 22nd Annual Needham Virtual Healthcare Conference

Rhythm Pharmaceuticals, Inc. today announced that David Meeker, M.D., Chair, Chief Executive Officer and President, will participate in a fireside chat at the 22nd Annual Needham Virtual Healthcare Conference on Monday, April 17, 2023.

April 10, 2023

·

8 min read